Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
about
Antifibrinolytic agent tranexamic acid for nasal haemorrhage (epistaxis)Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century.Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.Pharmacological therapy of vascular malformations of the gastrointestinal tract.Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasia.Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.Overview of small bowel angioectasias: clinical presentation and treatment options.Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
P2860
Q24236068-FB453736-60FB-4C3D-8906-157189AC754FQ34583622-A35F9CE2-8E46-4809-ADFF-93B7072A128BQ35059330-CB9F176D-0491-4E42-9F23-55DB8A7A21A0Q35544360-00DF22EA-5110-4DC7-832C-EC3C0DE6370EQ36426857-5D7D9F9E-27E9-4D11-A83B-C58414DD9917Q37419402-955F9A21-B22F-4A83-92E0-5A298E9BF108Q37971831-26CC38D9-2497-46DE-8B0F-504943088355Q38367321-953F7648-24B1-4EFD-8AAA-AD364C6B89F7Q43565795-3DED475E-9FAD-4B22-85B0-E45CBA4DFF15Q45850500-EE86AEFB-AEFB-4FF3-8A19-2D2A9CB7417DQ47906624-6537E2B1-14F9-46EE-AFA0-4F062EE32912Q48070397-2F45275A-5197-4700-B7DA-CCD14EC6D187
P2860
Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@en
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@nl
type
label
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@en
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@nl
prefLabel
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@en
Efficacy of unusually high dos ...... ry hemorrhagic telangiectasia.
@nl
P1476
Efficacy of unusually high dos ...... ary hemorrhagic telangiectasia
@en
P2093
P356
10.1056/NEJM200109203451216
P407
P577
2001-09-01T00:00:00Z